Company record
VITRUVIAS THERAPEUTICS INC
0 FDA warning letters since 2023 and 1 recall in the last 12 months.
Get an email the day FDA posts anything new about VITRUVIAS THERAPEUTICS INC.
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Sep 23 | Class I | VITRUVIAS THERAPEUTICS INC Drug |
Thyroid Tablets, USP, 1/2 Grain (30 mg), Each tablet contains: levothyroxine (T4) 19 mcg, liothyronine (T3) 4.5 mcg, 100 Tablets, Rx only, Distributed by: Vitruvias Therapeutics, Auburn, AL 36830, Product of USA, NDC 696… Superpotent Drug |